Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | +9.25% | +14.56% | +15.87% |
Mar. 28 | North American Morning Briefing : Stocks Set for -2- | DJ |
Jan. 30 | North American Morning Briefing : Microsoft Kicks Off Big Tech Bonanza | DJ |
Financials (USD)
Sales 2023 * | 57.85M | Sales 2024 * | 21.07M | Capitalization | 83.37M |
---|---|---|---|---|---|
Net income 2023 * | -27M | Net income 2024 * | -56M | EV / Sales 2023 * | 1.44 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 3.96 x |
P/E ratio 2023 * |
-3
x | P/E ratio 2024 * |
-1.6
x | Employees | 73 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 92.47% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | +9.25% | ||
1 week | +14.56% | ||
Current month | +30.04% | ||
1 month | +27.74% | ||
3 months | +13.58% | ||
6 months | -2.13% | ||
Current year | +15.87% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.92 | +9.25% | 1,509,045 |
24-03-27 | 0.8421 | +13.80% | 1,446,330 |
24-03-26 | 0.74 | -0.86% | 461,481 |
24-03-25 | 0.7464 | -3.98% | 499,849 |
24-03-22 | 0.7773 | -3.21% | 674,799 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.87% | 83.37M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-36.53% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |